Activate the first site for the NATIV3 Phase III trial of lanifibranor in NASH
Delivered after the deadline (70 days after the deadline)
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- 8 Sep 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“First site active – expected for the second quarter of 2021”
What we found
Evidence strength A What the grades mean
The company announced activation of the first NATiV3 clinical sites on September 8, 2021, after the end-of-Q2 2021 deadline. The July 2021 filing still listed first patient visit as a future milestone.
-
A Inventiva S.A. 20-F filed 2022-03-11
“On September 8, 2021, the Company announced the initiation of its NATiV3 Phase III clinical trial evaluating lanifibranor for the treatment of NASH. The first clinical trial sites have been activated in the United States” ✓ confirmed on the page
-
A Inventiva S.A. 6-K filed 2021-07-28
“First patient first visit of NATiV3 Phase III clinical trial evaluating lanifibranor in NASH – planned for the third quarter of 2021” ✓ confirmed on the page
-
A Inventiva S.A. 6-K filed 2021-09-08
“Activation of first clinical sites and start of patient screening” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Activate
- Deliverable
- First active site for NATIV3 Phase III trial
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Inventiva S.A.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-IVA-025121 · Corrections policy